GHP Q3 2021

32 GHP / Q3 2021 GHP / Q3 2021 33 , , CanaQuest Medical Corp has found its place in the world as a leader in the field of life science and pharmaceuticals. The teamhas developed twomaster formulations which could have an incredible impact on the pharmaceutical sector at large. Worthy winners in GHP’s rolling series of Global Excellence Awards, where the firmwas named Best Medical Cannabis and Botanical Oils Product Development Company, 2021 - North America, we thought it time to dig a little deeper into the secrets of their success. What does it mean to work in the rapidly expanding CBD field? For the team at CanaQuest, it means exploring new and exciting possibilities for development. There are now many companies proud to claim that their products have amazing benefits for many ailments, but few have conducted detailed scientific research and have the evidence to back up their claims. CanaQuest places a great deal of pride in its results, with the team’s products carefully developed through pre-clinical trials in conjunction with Dr. Steven Laviolette and his 13-member team at Western University. This academic background has been key to the team’s continued success, and the development of their two products Mentanine® and Mentabinol®. These products are specifically designed to treat multiple mental health ailments such as anxiety, depression, PTSD, schizophrenia, pain management and addiction. Mentanine® combines CBD isolate and Omega-3 compounds to produce a product with over ten times the efficacy for the treatment of anxiety, depression, and PTSD when compared to pure CBD. The evidence from scientific trials shows that it Quest for Excellence With plans to focus onmedical device and pharmaceutical companies in the coming 12 months, and the consultancy acumen to serve clients across a wide swathe of additional industries, Guide Consulting is the company helping businesses to integrate better practice. Working seamlessly to adapt its clients’ organisations for a changing world in terms of their operational practices and infrastructure, it made itself the ‘Best Medical Device ISO and QualityManagement Consultancy’ in 2021 for the United Kingdom. Guide Consulting serves a myriad of different clients across a variety of different industries, from engineering to construction, manufacturing, telecoms, transports, aerospace, defence, medical vehicles, pharmaceuticals, and digital software. Its expert ISO consultancy services have grown in renown over the years by way of client referrals and recommendations – and it is in this it finds its well-earned pride in its exemplary business model – ensuring it could carve out a niche for itself within a matter of years. Fundamentally, this naturalistic growth over time has secured it significant goodwill in its market segment, ensuring that whilst it has enjoyed a good rate of expansion, this rate has always been sustainable and to scale. This results in a consultancy that teaches clients how to manage their own systems effectively and empathically. Additionally, with it being so sector agnostic, its teaching has proven applicable across a multitude of different businesses with different goals and ways of working, just by focusing down on the requirements of the ISO standards and enabling them to incorporate these good practices into their everyday business model. In essence, Guide Restructure, Reorganise, Refocus May21811 Consulting seeks to ensure that a client will always be audit ready. Its helpful and personalised approach helps it to stand out from the crowd in its industry, as Guide Consulting will always seek to become more than just a consultant, but a partner; it will always work hard to gain an in-depth understanding of a business in order to put the client first and become ‘one of the team’ for each of them. Moreover, it does this with a prevailing internal culture of sharing ideas, gaining and sharing experience, and giving expert advice. Emboldening this company’s attitude towards constant and continued growth is the management team’s own attitude, one of always striving for the best and improving their own skills – it is with this that they are able to inspire the staff of Guide Consulting, and therefore the clients. Of course, even a company with a team as exemplary as this faces challenge. Over the past year or so, this has come in the form of the hurdles presented to Guide Consulting by the pandemic; the rise of remote auditing caused initial strain, as it removed the personal element that it has worked so hard to integrate into its process, and the on-site walkarounds became more difficult, if not impossible. Additionally, the onset of the pandemic caused many businesses to look into cutting costs wherever they could, which more often than not put their consultants at the top of this list of expenses to be cut. However, as industries began to find ways to manage, and Guide Consulting rallied the troops in order to reassure its clients that its work will still massively benefit them, it found it was able to move forward with helping clients to see the value in management systems, business continuity planning, and risk assessment. This ushered in a new era for the clients and the business alike wherein remote work was handled with sophistication and elegance from developing IT infrastructures from home to setting new, pandemic ready objectives. Due to this, it is looking forward to using the rest of 2021 to further develop the awareness of legal and regulatory compliance for its clients, implementing structures that will weed out drains on time and money in order to make its clients ready for a dynamic and successful future. Company: Guide Consulting Contact: Adele Sanders Website: guideconsulting.co.uk also has a significant effect on inflammation, which could be beneficial to those who suffer from pain. Because of the carefully calculated formula, Mentanine® requires lower doses of CBD which reduces the negative side-effects of high CBD consumption. Mentabinol®, on the other hand, acts as the only safer alternative medication to any THC product on the market. Unlike these products, it does not produce negative psychiatric side- effects. The team’s preclinical trials demonstrate a clear reversal of depression-like and schizophrenia-related symptoms, blockage of memory impairment, hyperactive activity and gene vulnerability. The benefits of working with Dr. Laviolette’s pre-clinical trial results are obvious, and have allowed the team a pathway to the initiation of human trials with select Universities. Thanks to this incredibly forward- thinking approach, CanaQuest is well on the way to becoming a global leader in the formulation and development of health products from cannabinoids and botanical derivatives. Unlike the competition, the focus on the serious scientific benefits of what they produce are certain to be the key behind the firm’s success in the broader market. The impact of COVID-19 on every industry has been immense, but for CanaQuest it has brought about both benefits and challenges. On the one hand, it has prevented the team from visiting the various facilities with which it has partnered, delaying rollout significantly. That said, the pandemic has allowed the team to explore other options with their products and it seems that Mentanine® could be an effective treatment for Long- Haulers Syndrome aftereffects. This path is currently being investigated by the team. Needless to say, both Mentanine® and Mentabinol® are well on their way to market, allowing the company to reinvest in clinical trials and the development of new Rx medical formulations. The development in the CBD field has been astonishing, but few have taken the care and provided the same depth of attention to detail as the team at CanaQuest. We celebrate their amazing achievement in the industry and look forward to seeing them grow rapidly as their products come to the attention of the general public. Company: CanaQuest Medical Corp Name: Paul Ramsay Email: [email protected] Web Address: www.canaquest.com

RkJQdWJsaXNoZXIy NTY1MjI4